AUG 20, 2019 2:37 PM PDT

Lab-on-a-chip Advances Search for Anti-Clotting Drugs

WRITTEN BY: Nouran Amin

A novel ‘lab-on-a-chip’ the size of a postage stamp could soon advance the developments of safer anti-clotting drugs for heart attack and stroke prevention. The effective use of current anti-clotting drugs are limited due to risk in complications which prompted the need for alternative therapeutics that can be safe to avoid the risk of a fatal bleed and strong enough for preventing blood clotting formation.

RMIT.EDU: The chip features a unique system of tiny channels and pumps for rapidly manipulating fluids.

Now, the new biocompatible lab-on-a-chip, which is detailed procedurally in the journal Analytical Chemistry, will help accelerate the search for new anti-clotting drugs. The development was designed to work with the complexity and sensitivity of the biology of blood.

"Blood is extremely sensitive to artificial surfaces and clots very easily, so blood-handling technologies must be equally sensitive," says lead investigator Dr. Warwick Nesbitt, who worked with various collaborators to pioneer the device. "We've combined a deep understanding of the biology of blood with precision microfabrication engineering and design, to deliver a device that can work with whole blood and produce reliable results.

The device can effectively function as a medical pathology laboratory onto a small chip, and uses quick automated processes that can be achieved in a few minutes which would instead take days in a full-sized lab. It features a system of micropumps and unique analysis tools to study the effectiveness of chemical compounds on blood clots.

Learn more about the early history of lab on a chip:

"We hope this powerful new tool will give researchers an edge in delivering better and safer anti-clotting treatments, to improve the health and wellbeing of millions around the world."

"It's a key step towards the development of quick and efficient microsystems for pre-clinical and clinical hematology screening and diagnostics,” says Dr. Crispin Szydzik on how the micro lab can mimic conditions inside blood vessels.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 20, 2020
Genetics & Genomics
APR 20, 2020
Advances in Gene Therapy for Neurons
New research may aid in the development of gene therapies for diseases like Alzheimer's and Parkinson's.
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
APR 20, 2020
Drug Discovery & Development
APR 20, 2020
First Successful Vaccine for Middle-East Respiratory Syndrome
Researchers have successfully completed the first-in-human clinical trial for a vaccine against MERS (Middle East Respir ...
APR 27, 2020
Cancer
APR 27, 2020
The Tumor Suppressor and its Regulator: An Indirect Oncogene
Oncogenes, mutations in genes that promote cancer growth, have long been easy targets for cancer research due to the dir ...
MAY 12, 2020
Drug Discovery & Development
MAY 12, 2020
Does Herbal Drink from Madagascar Cure COVID-19?
Andry Rajoelina, the president of Madagascar, an island off the coast of Southern Africa, has made claims that his count ...
MAY 19, 2020
Drug Discovery & Development
MAY 19, 2020
Can Chinese Drug Cure COVID-19 Without Vaccine?
Researchers at China’s Peking University have announced that they are developing a treatment capable of blocking C ...
Loading Comments...